Lincomycin is an antibiotic that cross-links in the circular region of the peptidyl transferase of 23S rRNA and inhibits bacterial protein synthesis.

1. Oral preparation is suitable for the treatment of respiratory tract infection, abdominal cavity infection, female genital tract infection, pelvic cavity infection, skin and soft tissue infection caused by sensitive staphylococcus, streptococcus, pneumococcus and anaerobic bacteria.

2. In addition to the above mentioned infection, injection preparation can be used to treat severe infections caused by streptococcus, pneumococcus and staphylococcus, such as sepsis, bone and joint infection, surgical adjuvant treatment for chronic bone and joint infection, and acute blood-borne osteomyelitis caused by staphylococcus.

3. Lincomycin hydrochloride can also be used for the treatment of infectious diseases allergic to penicillin or not suitable for the use of penicillin drugs.